Pamidronate Disodium (Areva Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Pamidronate Disodium drug offered from Areva Pharmaceuticals Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Areva Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Pamidronate Disodium
SUBSTANCE NAME: PAMIDRONATE DISODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-08-06
END MARKETING DATE: 0000-00-00


Pamidronate Disodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPamidronate Disodium from Areva Pharmaceuticals Inc.
LABELER NAME: Areva Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3(mg/mL)
START MARKETING DATE: 2013-08-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59923-601_776a4d0d-0b86-76f9-9440-21360ae6b569
PRODUCT NDC: 59923-601
APPLICATION NUMBER: ANDA077433

Other PAMIDRONATE DISODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Pamidronate Disodium
APP Pharmaceuticals, LLCPamidronate Disodium
Areva Pharmaceuticals Inc.Pamidronate Disodium
Hospira, Inc.Pamidronate Disodium
Mylan Institutional LLCPamidronate Disodium
Pfizer Laboratories Div Pfizer IncPamidronate Disodium
Teva Parenteral Medicines, Inc.Pamidronate Disodium